ReBuilder Medical Technologies, Inc. Reports LOI With National DME Distributor

.

CHARLES TOWN, W.Va., Sept. 29 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) announced today that they have penned a letter of intent with a major national Durable Medical Equipment company to introduce the ReBuilder for neuropathy and arthritis to DMEs throughout the country.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO)

"We expect to have a signed agreement in place within the next week," says David B. Phillips, Ph.D., the CEO of RBRM.

Additionally, Dr. Phillips reports: "We already have DMEs calling us because of the tremendous demand created by the acceptance of our neuropathy and arthritis products from patients who have already gone to their doctors and secured a prescription."

John Romanic, one of the principals of the national distributor added, "We are in a unique position to promote the ReBuilder to DMEs because of the wonderful success we have had with the ReBuilder with patients who suffer from neuropathy or arthritis pain. We expect to introduce and sign up to 100 suppliers to the ReBuilder this year."

With the acceptance of Medicare, sales have increased dramatically for RBRM. Diabetic patients develop neuropathy as a complication to their diabetes, and arthritis is increasing with the graying of America.

Inquiries can be made at www.rebuildermedical.com.

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.